# Dopamine

## Dopamin inj 200mg/5mL

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IDOPA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Indications        | Correction of poor perfusion， low cardiac output， impending renal failure & shock associated with MI， trauma， endotoxic septicemia， open heart surgery， heart failure.                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Must be diluted before infusion. Adult usual dosage: Initially， 1-5 mcg/kg/minute， increased gradually by 1-4 mcg/kg/minute in every 10-15 minutes according to patient's cardiac and urine output， blood pressure. Chronic refractory congestive heart failure: Initially， 0.5-2 mcg/kg/minute and increased gradually until the desired response is obtained. Severely ill patients: Initially， 5 mcg/kg/min， increased gradually by 5-10 mcg/kg/minute until the desired response is obtained. Maximum: 20-50 mcg/kg/minute. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Phaeochromocytoma; uncorrected hypovolaemia; uncorrected tachyarrhythmia or ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Most frequently: ectopic beats， nausea， vomiting， tachycardia， anginal pain， palpitations， dyspnoea， headache， hypotension & vasoconstriction. Other infrequent side effects include aberrant conduction， bradycardia， piloerection， widened QRS complex， azotaemia & hypertension.                                                                                                                                                                                                                                       |
| Pregnancy          | Compatible – maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

